NEW YORK (GenomeWeb News) – WaferGen Biosystems has raised gross proceeds of approximately $6.2 million through a series of private placements between June 16 and Aug. 31, the firm said today.

The publicly traded maker of gene expression and genotyping systems said that it issued roughly 5 million shares of common stock at a price of $1.25 per share, along with warrants to purchase 1,502,700 shares of common stock, at an exercise price of $2 per share. The warrants have a five-year term, the firm said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.